Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Sep 28;76(9):93C-97C.
doi: 10.1016/s0002-9149(99)80477-9.

What benefit can be derived from treating normocholesterolemic patients with coronary artery disease?

G Brown  1 , B F Stewart, X Q Zhao, L A Hillger, D Poulin, J J Albers
Affiliations
Review

What benefit can be derived from treating normocholesterolemic patients with coronary artery disease?

G Brown et al. Am J Cardiol. .

Abstract

Controversy still remains regarding the possible clinical or arteriographic benefit of intensive lipid-altering therapy in patients who have coronary artery disease and apparently normal lipid levels. Resolution of this controversy appears to depend on an improved understanding of the role of variables other than total or low density lipoprotein cholesterol levels. A comparison of the "normolipidemic" subgroup of The Familial Atherosclerosis Treatment Study patients and The Harvard Atherosclerosis Reversibility Project patients indicates that low levels of high density lipoprotein cholesterol and elevated levels of apolipoprotein B appear to increase considerably the likelihood of benefit from intensive lipid-altering therapy. Other risk-related variables such as systolic blood pressure and lipoprotein(a) further contribute to the prediction of risk and possibly to the potential for treatment benefit.

PubMed Disclaimer

Similar articles

See all similar articles

Publication types

LinkOut - more resources